Howard Jeffrey Weinstein MD
Chief, Peds Hem-Onc at MassGeneral Hosp. for Children
Join to View Full Profile
55 Fruit StYaw 8B Pediatric Hematology OncologyBoston, MA 02114
Phone+1 617-724-3315
Fax+1 617-724-8526
Dr. Weinstein is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Howard Weinstein is a pediatric hematologist/oncologist in Boston, MA and is affiliated with multiple hospitals in the area, including Massachusetts General Hospital and Newton-Wellesley Hospital. He received his medical degree from University of Maryland School of Medicine and has been in practice 45 years. He is experienced in acute myeloid leukemia, hodgkin's lymphoma, pediatric non-hodgkin's lymphoma, healthcare outcomes research, and combined modality therapy.
Education & Training
Boston Children’s Hospital/Boston Medical CenterFellowship, Pediatric Hematology/Oncology, 1975 - 1977
National Institutes of Health Clinical CenterFellowship, Hematology and Medical Oncology, 1974 - 1975
Mass General Brigham/Massachusetts General HospitalResidency, Pediatrics, 1972 - 1974
University of Maryland School of MedicineClass of 1972
Certifications & Licensure
MA State Medical License 1975 - 2027
MD State Medical License 1974 - 1991
American Board of Pediatrics Pediatrics
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2002-2014
- Boston Magazine Castle Connolly, 2008-2013
- America's Top Doctors for Cancer Castle Connolly, 2005-2013
- Join now to see all
Clinical Trials
- Isotretinoin With or Without Dinutuximab, Aldesleukin, and Sargramostim Following Stem Cell Transplant in Treating Patients With Neuroblastoma Start of enrollment: 2001 Oct 18
- Combination Chemotherapy, Autologous Stem Cell Transplant, and/or Radiation Therapy in Treating Young Patients With Extraocular Retinoblastoma Start of enrollment: 2008 May 06
- Neuropsychological and Behavioral Testing in Younger Patients With Cancer Start of enrollment: 2009 Feb 27
- Join now to see all
Publications & Presentations
PubMed
- Disease site number was not prognostic in a low-risk Hodgkin lymphoma combined modality trial: revisiting PHC HOD90.Angela M Feraco, Yiwang Zhou, Ying Zheng, Lianna J Marks, Alison Friedmann
Blood Advances. 2023-11-14 - 12 citationsOutcomes of a clinical pathway for primary outpatient management of pediatric patients with low-risk febrile neutropenia.Jonathan Paolino, Juliana Mariani, Alexandra Lucas, Jeremy Rupon, Howard J. Weinstein
Pediatric Blood & Cancer. 2019-07-01 - 19 citationsExcellent outcomes in children and adolescents with CNS+ Burkitt lymphoma or other mature B-NHL using only intrathecal and systemic chemoimmunotherapy: results from FA...J. Kimble Frazer, Kevin J. Li, Paul J. Galardy, Sherrie L. Perkins, Anne Auperin
British Journal of Haematology. 2019-04-01
Press Mentions
Brookline Residents Inspired to Run Marathon for Mass. GeneralMarch 23rd, 2018
Weymouth Oncology Nurse Sets Sights on Boston MarathonApril 13th, 2019
Professional Memberships
- Member
Other Languages
- French
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
